DHANGADI, MAY 20
Shortage of very essential medicines used for the treatment of COVID patients has hit Sudurpaschim hard.
Medicines such as meropenum, leprofloksasin, and heparin, among others, have protected patients from blood infection and pneumonia. However, the crisis of these very important medicines have hit the province hard.
Doctors involved in the treatment of patients said that shortage of vitamin C; zinc, dexamethason and remdesivir, among other essential medicines, have hit hospitals in the province.
With patients facing shortage of oxygen, treatment has become even more difficult due to unavailability of medicines. The number of patients needing ICU and HDU has also increased. Mahakali Hospital COVID contact person Dr Govinda Rokaya said medicines needed for patients at ICU and HDU were unavailable in the market. Rokaya further added that the market lacked the meropenum, leprofloksasin, heparin, vitamin C; zinc, dexamethason and remdesivir.
It is very difficult to find medicines required for treatment of COVID patients in Dhangadi.
Dr Anil Dhakal, consultant physician in Kailali Hospital, said the medicine crunch had added more problems.
A version of this article appears in the print on May 21, 2021, of The Himalayan Times.
